共 50 条
- [33] Seropositive Rheumatoid Arthritis Patients with an Inadequate Response to Tumor Necrosis Factor Inhibitors Achieve Improved Clinical Effectiveness After Switching to Rituximab Versus Switching to an Alternative Tumor Necrosis Factor Inhibitor ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S203 - S203
- [36] Meta-analysis of IL-17 inhibitors in two populations of rheumatoid arthritis patients: biologic-naïve or tumor necrosis factor inhibitor inadequate responders Clinical Rheumatology, 2019, 38 : 2747 - 2756